A human leukemia cell line made resistant to two folate analogues, trimetrexate and N¹⁰-propargyl-5,8-dideazafolic acid (CB3717)TAKEMURA, Y; OHNUMAT; MIYACHI, H et al.Journal of cancer research and clinical oncology. 1991, Vol 117, Num 6, pp 519-525, issn 0171-5216Conference Paper

A novel human monoclonal antibody, tono-1, reactive with T-lymphocytic leukemia cellsNUMASAKI, M; FUKUOKA, Y; KUDO, T et al.International journal of cancer. 1995, Vol 62, Num 1, pp 42-47, issn 0020-7136Article

DNA damage in human T-lymphoblastoid cell line Molt-3 induced by reative oxygen speciesRANJBAR, S; HANNIGAN, B. M.Mutation research. 1993, Vol 285, Num 2, pp 225-228, issn 0027-5107Article

The proposed 5'-nucleotidase inhibitor in human leukemic cells in an artefactDORNAND, J; BONNAFOUS, J.-C; FAVERO, J et al.Biochimica et biophysica acta. 1984, Vol 804, Num 4, pp 398-403, issn 0006-3002Article

Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitroOHNUMA, T; LI, F.-L; HOLLAND, J. F et al.Anticancer research. 1997, Vol 17, Num 4A, pp 2455-2458, issn 0250-7005Article

Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozymeKOBAYASHI, H; DORAI, T; HOLLAND, J. F et al.Cancer research (Baltimore). 1994, Vol 54, Num 5, pp 1271-1275, issn 0008-5472Article

Cadmium induces apoptosis differentially on immune system cell linesTSANGARIS, G. T; TZORTZATOU-STATHOPOULOU, F.Toxicology (Amsterdam). 1998, Vol 128, Num 2, pp 143-150, issn 0300-483XArticle

Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leukemic cells; involvement of reactive oxygen radicals and protein kinase CHAYON, T; DVILANSKY, A; ORIEV, L et al.Anticancer research. 1999, Vol 19, Num 3A, pp 2089-2093, issn 0250-7005Article

Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine : mechanism of inoculum effectsKOBAYASHI, H; TAKEMURA, Y; OHNUMA, T et al.Cancer chemotherapy and pharmacology. 1992, Vol 31, Num 1, pp 6-10, issn 0344-5704Article

Cytotoxic activity and antiproliferative effects of a new semi-synthetic derivative of ent-3β-hydroxy-13-epi-manoyl oxide on human leukemic cell linesDIMAS, K; DEMETZOS, C; MITAKU, S et al.Anticancer research. 1999, Vol 19, Num 5B, pp 4065-4072, issn 0250-7005Article

Glycoprotein of human immunodeficiency virus type 1 synthesized in chronically infected Molt3 cells acquired heterogeneous oligosaccharide structuresRANAJIT PAL; DI MARZO VERONESE, F; NAIR, B. C et al.Biochemical and biophysical research communications (Print). 1993, Vol 196, Num 3, pp 1335-1342, issn 0006-291XArticle

Effects of CPT-11 in combination with other anti-cancer agents in cultureKANO, Y; SUZUKI, K; AKUTSU, M et al.International journal of cancer. 1992, Vol 50, Num 4, pp 604-610, issn 0020-7136Article

Cellular pharmacology of 1-β-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cellsMOMPARLER, R. L; ONETTO-POTHIER, N; BOUFFARD, D. Y et al.Cancer chemotherapy and pharmacology. 1990, Vol 27, Num 2, pp 141-146, issn 0344-5704, 6 p.Article

Demonstration of thymopoietin transcripts in different hematopoietic cell linesBERGER, R; THEODOR, L; BROK-SIMONI, F et al.Acta haematologica. 1995, Vol 93, Num 2-4, pp 62-66, issn 0001-5792Conference Paper

Protection of leukemic cells by deoxycytidine : In vitro measures of protection against cytosine arabinosideCOHEN, J. D; STROCK, D. J; LAGUARDIA, E. A et al.Leukemia research. 1998, Vol 22, Num 5, pp 421-427, issn 0145-2126Article

Expression of nuclear lectin carbohydrate-binding protein 35 in human immunodeficiency virus type 1-infected molt-3 cellsSCHRÖDER, H. C; USHIJIMA, H; THEIS, C et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1995, Vol 9, Num 4, pp 340-348, issn 1077-9450Article

Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell linesLI, X.-K; KOBAYASHI, H; HOLLAND, J. F et al.Leukemia research. 1993, Vol 17, Num 6, pp 483-490, issn 0145-2126Article

Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell lineKANO, Y; SUZUKI, K; AKUTSU, M et al.Leukemia. 1992, Vol 6, Num 5, pp 440-445, issn 0887-6924Article

Clinically relevant deoxycytidine levels are high enough to profoundly alter 9-β-D-arabinofuranosylguanine cytotoxicity for human T-cell acute leukemia cells in vitroCOHEN, J. D; STROCK, D. J; TEIK, J. E et al.Pediatric hematology and oncology. 1999, Vol 16, Num 3, pp 239-244, issn 0888-0018Article

The effect of sclareol on growth and cell cycle progression of human leukemic cell linesDIMAS, K; KOKKINOPOULOS, D; DEMETZOS, C et al.Leukemia research. 1999, Vol 23, Num 3, pp 217-234, issn 0145-2126Article

The effects of copper deficiency on human lymphoid and myeloid cells : an in vitro modelTONG, K. K; HANNIGAN, B. M; MCKERR, G et al.British journal of nutrition. 1996, Vol 75, Num 1, pp 97-108, issn 0007-1145Article

Lymphokine-independent, leukemia cell-mediated induction of tumor necrosis factor in human monocytesYAMAUCHI, T; SAGAWA, T; KANOH, M et al.Cancer research (Baltimore). 1990, Vol 50, Num 9, pp 2708-2712, issn 0008-5472, 5 p.Article

Amplification of the thymidylate synthase gene in an N¹⁰-propargyl-5,8-dideazafolic-acid-resistant human leukemia, MOLT-3 cell line developed in pteroyglutamic acid, but not in leucovorinMIYACHI, H; TAKEMURA, Y; KOBAYASHI, H et al.Journal of cancer research and clinical oncology. 1996, Vol 122, Num 11, pp 659-664, issn 0171-5216Article

Deoxyribonucleoside triphosphate pools and thymidine chemosensitization in human T-cell leukemiaCOHEN, J. D; ROBINS, H. I; KATZ, T. B et al.Leukemia research. 1993, Vol 17, Num 2, pp 167-174, issn 0145-2126Article

Specificity of ribozyme designed for mutated DHFR mRNAKOBAYASHI, H; KIM, N; HALATSCH, M.-E et al.Biochemical pharmacology. 1994, Vol 47, Num 9, pp 1607-1613, issn 0006-2952Article